Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential change of NTBI and iron metabolic markers after oral iron in hemodialysis patients
jRCT1091220300Recruiting
- Sponsor
- Shigeru miyazaki
- Start
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of ferrous sulfate in anemia of renal disease, sponsored by Shigeru miyazaki. Primary endpoints: Sequential serum NTBI concentration after oral ferrous sulfate and Sequential changes in iron metabolic markers after oral ferrous sulfate. Started Jun 2017; status: recruiting.
02
Drugs
ferrous sulfate
03
Conditions
anemia of renal disease
Beyond the preview
Go deeper on jRCT1091220300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1091220300.